RC

Ramakrishna Chowdhury Kantipudi

Active Director Director DIN 09624915
DIN 09624915 First appointment May 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramakrishna Chowdhury Kantipudi

Data last updated:

Ramakrishna Chowdhury Kantipudi is a Director at Areli Pharmaceuticals Private Limited (since 2022). The company operates in Pharma.

DIN 09624915
Primary Designation Director
Industry Pharma
First Appointment 30 May 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 May 20222022Active

Board colleagues of Ramakrishna Chowdhury Kantipudi

NameDINCompanyDesignation
Pendyala Pardha Saradhi Kishore07000231Areli Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Areli Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ramakrishna Chowdhury Kantipudi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramakrishna Chowdhury Kantipudi

Ramakrishna Chowdhury Kantipudi currently holds 1 directorship: Areli Pharmaceuticals Private Limited (Director, since 30 May 2022).

Ramakrishna Chowdhury Kantipudi was first appointed on 30 May 2022 as Director at Areli Pharmaceuticals Private Limited.

The current boards of Ramakrishna Chowdhury Kantipudi's companies include Pendyala Pardha Saradhi Kishore (Areli Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available